NEJM AIDS-Related Articles
The New England Journal of Medicine in its Aug. 25 issue published three articles examining HIV vaccine development efforts and how drug patents and stigma affect access to antiretrovirals. The articles include:
- "Patents versus Patients? Antiretroviral Therapy in India": Diane Havlir, a professor of medicine at the University of California-San Francisco and chief of the HIV/AIDS Division at San Francisco General Hospital, and Scott Hammer, a professor of medicine at Columbia University College of Physicians and Surgeons and chief of the Division of Infectious Diseases at Columbia University Medical Center and New York-Presbyterian Hospital, examine how laws regulating generic antiretroviral production in India might affect the millions of HIV-positive people worldwide in need of treatment (Havlir/Hammer, NEJM, 8/25).
- "Curing Stigma: the Limits of Antiretroviral Access": Oni Blackstock of the Montefiore Medical Center in New York examines the effects that the stigma surrounding HIV/AIDS has on those living with the disease (Blackstock, NEJM, 8/25).
- "The Search for Effective HIV Vaccines": Howard Markel, a professor of the history of medicine and of pediatrics and communicable diseases at the University of Michigan Medical School, looks at the challenges and obstacles in developing safe and effective HIV vaccines (Markel, NEJM, 8/25).